eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Cephalon (UK) Limited

Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone: +44 (0) 207 5407117
Fax: +44 (0) 207 4507349
WWW: http://www.tevauk.com
Medical Information Direct Line: +44 (0) 207 5407117
Medical Information e-mail: medinfo@tevauk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 10/01/2011
PIL Zanaflex 2 and 4mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 23/04/2010 and displayed until 10/01/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 09/04/2010 and displayed until 23/04/2010
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 23/10/2009 and displayed until 09/04/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/07/2009 and displayed until 23/10/2009
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 27/08/2008 and displayed until 19/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 15/07/2008 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 24/04/2008 and displayed until 15/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/03/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change of contra-indications
Updated on 01/08/2006 and displayed until 13/03/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/08/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 07/08/2000 and displayed until 01/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   tizanidine hydrochloride